Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 346,659 | 31,540 | 24,160 | 71,454 | 34,851 |
| Marketable Securities | 467,402 | 156,250 | 221,480 | 208,217 | 95,508 |
| Receivables | 33,906 | 5,950 | 0 | 0 | 0 |
| Other current assets | 5,970 | 1,450 | 3,060 | 1,952 | 1,791 |
| TOTAL | $857,431 | $195,190 | $248,700 | $281,623 | $132,150 |
| Non-Current Assets | |||||
| PPE Net | 43,961 | 24,480 | 14,470 | 11,095 | 8,663 |
| Investments And Advances | 7,426 | 2,270 | 0 | 0 | 2,316 |
| Other Non-Current Assets | 32,318 | 10,490 | 3,160 | 2,886 | 370 |
| TOTAL | $83,705 | $37,240 | $17,630 | $13,981 | $11,349 |
| Total Assets | $941,136 | $232,440 | $266,340 | $295,604 | $143,499 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,438 | 2,970 | 2,800 | 4,247 | 1,391 |
| Accrued Expenses | 28,018 | 11,170 | 7,540 | 6,385 | 2,755 |
| Other current liabilities | N/A | 2,000 | 0 | 556 | 0 |
| TOTAL | $69,856 | $18,510 | $13,100 | $13,698 | $7,056 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 28,329 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 345,000 | 0 | 0 | 0 | 0 |
| TOTAL | $357,269 | $4,690 | $7,030 | $5,905 | $5,617 |
| Total Liabilities | $427,125 | $23,210 | $20,130 | $19,603 | $12,673 |
| Shareholders' Equity | |||||
| Common Shares | 735 | 250 | 250 | 252 | 211 |
| Retained earnings | -248,299 | -190,820 | -149,860 | -116,775 | -96,944 |
| Other shareholders' equity | 4,053 | -1,080 | 660 | 152 | 49 |
| TOTAL | $514,011 | $209,230 | $246,210 | $276,001 | $130,826 |
| Total Liabilities And Equity | $941,136 | $232,440 | $266,340 | $295,604 | $143,499 |